Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-393-4 | CAS number: 54914-37-3
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1985-05-29 to 1985-06-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- (1981)
- Deviations:
- no
- GLP compliance:
- no
Test material
- Reference substance name:
- 1,3,3-trimethyl-N-(2-methylpropylidene)-5-[(2-methylpropylidene)amino]cyclohexanemethylamine
- EC Number:
- 259-393-4
- EC Name:
- 1,3,3-trimethyl-N-(2-methylpropylidene)-5-[(2-methylpropylidene)amino]cyclohexanemethylamine
- Cas Number:
- 54914-37-3
- Molecular formula:
- C18H34N2
- IUPAC Name:
- 1,3,3-Trimethyl-N-(2-methylpropylidene)-5-[(2-methylpropylidene)amino]cyclohexanemethanamine
- Test material form:
- other: liquid
- Details on test material:
- Produced October 1980. Purity 95 %
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- other: Small white Russian, Chbb-SPF
- Details on test animals or tissues and environmental conditions:
- - Source: Dr. Karl Thomae GmbH, Biberach (Germany)
- Sex: male and female
- Weight at study initiation: 2.0 - 2.6 kg
- Number of animals: 3 males, 3 females
- Controls: untreated eye
Test system
- Vehicle:
- unchanged (no vehicle)
- Amount / concentration applied:
- undiluted
Amount applied: 0.1 ml - Duration of treatment / exposure:
- 72 hour(s)
- Observation period (in vivo):
- Postexposure observation period: 12 days
- Number of animals or in vitro replicates:
- 6
- Details on study design:
- Comment: rinsed after (see exposure time)
EXAMINATIONS
- Ophtalmoscopic examination: 1, 24, 48, 72 hours, 5, 7, 9, and 12 days after treatment
- Tool used to assess score: sodium fluorescein / ophthalmic lamp / visual inspections
- Scoring system: Draize (1959); evaluation: VCI notes on safety data sheet and Appendix VI of 79/831/EEC
Results and discussion
In vivo
Results
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- other: according to scoring system
- Score:
- 18.21
- Max. score:
- 110
- Reversibility:
- fully reversible within: 12 days
- Remarks on result:
- other: REVERSIBILITY: complete in 12 days except for alopecia on the margin of the lower eyelid of one animal
- Irritant / corrosive response data:
- AVERAGE SCORE
- Cornea: 0.72
- Iris: 0.33
- Conjunctivae (Redness): 2.06
- Conjunctivae (Chemosis): 0.61
- Overall irritation score: 18.21/110
DESCRIPTION OF LESIONS: transient reddening of parts of the iris in the females
REVERSIBILITY: complete in 12 days except for alopecia on the margin of the lower eyelid of one animal
Applicant's summary and conclusion
- Conclusions:
- The crosslinking agent
1,3,3 -trimethyl-N-(2 -methylpropylidene)-5 -[(2 -methylpropylidene)amino]cyclohexanemethylamine
(VESTAMIN A 139), tested with one undiluted administration of 0,1 m3 to eyes or eyelid sac of male and female rabbits showed slightly irritating effects (OECD 405, 1981). - Executive summary:
The test substance tested with one undiluted administration of 0,1 m3to eyes or eyelid sac of male and female rabbits showed slightly irritating effects (OECD 405, 1981).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
